Genoray Co., Ltd. (KOSDAQ:122310)
South Korea
· Delayed Price · Currency is KRW 4,070.00
+20.00 (0.49%)
At close: Mar 6, 2026
Genoray Revenue
Genoray had revenue of 21.83B KRW in the quarter ending September 30, 2025, a decrease of -8.89%. This brings the company's revenue in the last twelve months to 102.75B, down -5.71% year-over-year. In the year 2024, Genoray had annual revenue of 106.98B with 9.28% growth.
Revenue (ttm)
102.75B
Revenue Growth
-5.71%
P/S Ratio
0.47
Revenue / Employee
285.42M
Employees
360
Market Cap
48.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 106.98B | 9.08B | 9.28% |
| Dec 31, 2023 | 97.90B | 15.29B | 18.51% |
| Dec 31, 2022 | 82.60B | 8.31B | 11.19% |
| Dec 31, 2021 | 74.29B | 12.60B | 20.43% |
| Dec 31, 2020 | 61.69B | -3.42B | -5.25% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DRGEM | 98.34B |
| JPI Healthcare | 52.79B |
| UXN Co., Ltd. | 21.18M |
| Neofect | 20.50B |
| Genesystem | 345.38M |
| Hironic | 33.18B |
| CU Medical Systems | 44.79B |
| QuantaMatrix | 3.35B |